Background. Many critically ill patients with 2009 pandemic influenza A (H1N1) (2009 H1N1) infection were noted to be obese, but whether obesity, rather than its associated co-morbidities, is an independent risk factor for severe infection is unknown.
Early in the pandemic, concurrent with national and international reports [3] [4] [5] [6] [7] [8] [9] [10] [11] , we observed that many adults with severe 2009 H1N1 infection were obese (11) . However, co-morbidities, small numbers of patients, and other limitations have made it difficult for other investigators to confirm obesity as an independent risk factor for severe 2009 H1N1 infection. Prior to the pandemic, the conditions associated with severe seasonal influenza in the literature or subsequently incorporated into the recommendations of the US Advisory Committee on Immunization Practices (ACIP) did not include obesity but did include chronic pulmonary and cardiac diseases and diabetes, which are conditions that are more common among the obese population. Some conditions that are linked with severe seasonal influenza by the ACIP, including chronic lung disease, immunosuppression, and pregnancy, also appear to increase the risk of severe 2009 H1N1 infection [14] . We analyzed public health surveillance data from .500 adults hospitalized in California during the first 4 months of the pandemic to test the hypothesis that obesity, rather than its co-morbidities, is an independent risk factor for fatal 2009 H1N1 influenza.
METHODS
A case patient was defined as a California resident who was hospitalized for >24 h with influenza-like symptoms and had laboratory detection by polymerase chain reaction (PCR) of 2009 H1N1 influenza virus or of influenza A virus that was nonsubtypeable for human subtypes H1 and H3 by PCR. We studied cases reported during the period from 20 April through 11 August 2009 by health care providers to local health departments, which subsequently reported them to the CDPH. Staff at the local health department or the CDPH recorded data on patient height, weight, demographic characteristics, clinical presentation and course, co-morbid conditions, and laboratory and radiographic findings that were contained in hospital records from the emergency department, hospital admission, infectious disease physician consultations, radiographic and microbiologic studies, transfers, and hospital discharges onto a standardized case report form. Cause of death was determined from review of medical records or death certificates by local health department or CDPH staff.
Body mass index (BMI) was calculated from available height and weight data as body weight in kilograms divided by the square of height in meters. Adult obesity was defined as BMI >30 in accordance with the National Institutes of Health (NIH) classification [15] . Among reported case patients with BMI data, we analyzed the following: NIH BMI subcategories of ,18.5 (underweight), 18.5-24 (normal), 25-29 (overweight), 30-34 (obese class I), 35-39 (obese class II), and >40 (obese class III, or extreme obesity) [15] . We observed a high prevalence of obesity class III case patients, among whom we analyzed an additional subcategory of BMI >45. Because the standard definitions for obesity differ for persons aged ,20 years (defined as age-specific BMI percentile by sex [16] ), we limited our analyses to persons >20 years of age. Pregnant women were excluded, because the standard definitions of obesity are not available for this population. Fatal cases among individuals who died at home or were hospitalized ,24 h were also excluded from all analyses.
The distributions of demographic and clinical risk factors, clinical course, and survival were compared between case patients with and those without BMI data using v 2 testing with an a of 0.05. For case patients with BMI data, the association of BMI and demographic and clinical characteristics with survival was assessed in bivariate analysis using odds ratios [ORs] and a standard v 2 statistic. A trend test was performed to assess the relationship of survival, demographic, and clinical characteristics with increasing BMI. Preexisting co-morbidities significantly associated both with death and with BMI in bivariate analysis at a 5 0.10 were analyzed by multivariate logistic regression using backward elimination. Only risk factors (eg, preexisting comorbidities at the time of onset of symptoms) that were significant in the multivariate analysis at a 5 0.05, along with race/ ethnicity and sex, were retained in the final model. Two separate multivariate analyses were performed using: (1) all NIH subcategories (underweight, normal weight, overweight, obese class I, obese class II, and obese class III) and (2) all NIH subcategories with an additional obese class III subcategory of BMI >45. Missing data were excluded from the bivariate analyses, but a missing category was included for each covariate in the multivariate analyses to maximize statistical power. All data were analyzed using SAS, version 9.2 (SAS Institute). This activity was reviewed by the California Committee for the Protection of Human Subjects and was determined to be a public health response that did not require institutional review board approval.
RESULTS
During the period 20 April-11 August 2009, 1088 case patients who were hospitalized with or died due to 2009 H1N1 infection were reported in California, of whom 1076 were hospitalized >24 h. Three hundred seventy-five case patients ,20 years of age and 82 pregnant case patients were excluded from further analyses. Of 619 case patients eligible for inclusion in the study, 534 (86%) had BMI data recorded. 2009 H1N1 influenza virus was prevalent and predominant in this period; from 14 June through 31 July 2009, the virus accounted for 50% of cases of influenza-like illness tested and 92%-100% of influenza virus infections identified through statewide surveillance.
As indicated in Table 1 , of the 534 case patients with BMI data recorded, 256 (48%) were male. Age distribution included 181 case patients 20-35 years of age (34%), 125 case patients 36-49 years of age (23%), and 228 case patients >50 years of age (43%). Of 500 case patients for whom data were available, 192 (38%) were non-Hispanic white, and 163 (33%) were Hispanic. Of 524 case patients for whom data were available, 378 (72%) had a reported co-morbid condition associated by the ACIP with severe seasonal influenza. Of 534 case patients for whom BMI information were available, 274 (51%) were reported to be obese (BMI .30), including 108 (20%) with a BMI 30-34, 63 (12%) with a BMI of 35-39, and 103 (19%) with a BMI >40. Of case patients with a BMI >40, 61 had a BMI > 45 (11% of all 534 case patients).
Ninety-two case patients (17%) died; of these, 56 (61%) were obese, including 17 (18%) with a BMI 30-34, 11 (12%) with a BMI of 35-39, and 28 (30%) with a BMI >40; 21 of the case Figure 1 ). Four case patients who died (age range, 28-72 years) were underweight (BMI ,18.5); each of these 4 patients had multiple co-morbidities, including chronic lung disease (3) and immunosuppression (2) .
In bivariate analyses of underlying co-morbidities associated with death, case patients who died were more likely than survivors to be >50 years of age (P 5 .04) or to have underlying obstructive sleep apnea (P 5 .01), congestive heart failure (P 5 .02), renal disease (P 5 .02), immunosuppression (P 5 .005), or (5) 13 (14) 15 ( c Conditions listed are not mutually exclusive because of the presence in some patients of multiple underlying chronic diseases.
d Includes pulmonary hypertension, bronchiectasis, interstitial lung disease, restrictive lung disase, pulmonary fibrosis, cystic fibrosis, status-post tracheostomy, bronchopulmonary dysplasia/respiratory distress syndrome, bronchiolitis obliterans organizing pneumonia, tracheo/bronchomalacia, and history of pulmonary emboli e Includes atrial fibrillation, valvular disease, hypertensive heart disease, and history of endocarditis/myocarditis.
f Includes pituitary, thyroid, and adrenal disorders.
g Includes congenital immunodeficiency, status-post splenectomy, and adrenal disease.
h Includes Parkinson disease, dementia, status-post cerebrovascular accident, intraventircular hemmorhage, hydrocephalus status-post ventriculoperitoneal shunt, central nervous system malignancy, microcephaly, myasthenia gravis, chronic encephalopathy, muscular dystrophy, multiple sclerosis, para/quadriplegia, neurodegenerative disease not otherwise specified, and peripheral neuropathy.
i Includes status-post gastrostomy tube placement, gastritis, cholelithiasis, history of small bowel obstruction, short gut syndrome, pyloric stenosis, Hirschsprung disease, diverticuosis/diverticulitis, chronic hepatitis/cirrhosis, biliary atresia, pancreatic insufficiency, gastroparesis, necroenterocolitis, ulcerative colitis, Chrohns disease, and chronic graft versus host disease.
j Includes Staphylococcus aureus of all susceptibility patterns, group A Streptococcus, Streptococcus pneumoniae, gram-negative rods, and other bacteria.
class III (extreme) obesity (BMI >40 [P 5 .04] and BMI >45 [P 5 .005]), and they were less likely than other case patients to have asthma (P 5 .06). With regard to hospital course, case patients who died were also more likely than other case patients to have abnormal chest radiograph findings (P , .001), require intensive care (P , .001) or mechanical ventilation (P , .001), have secondary bacterial infection (P 5 .002), and require longer hospitalization (P , .001), and they were less likely to receive antiviral treatment (P 5 .02) ( Table 1) . Table 2 shows the association of demographic factors, underlying co-morbid conditions, and selected clinical course variables with BMI categories. The proportion of case patients who were male significantly decreased with increasing BMI. Likewise, the proportion of case patients with certain chronic pulmonary diseases (eg, asthma and obstructive sleep apnea), diabetes mellitus, and hypertension significantly increased with increasing BMI, whereas chronic neurologic disorders (eg, cerebral palsy/developmental delay, miscellaneous neurologic disorders), miscellaneous chronic lung disease, and miscellaneous gastrointestinal disorders (eg, presence of gastrostomy tube) significantly decreased with increasing BMI. The proportion of case patients who required mechanical ventilation and the proportion of patients who died also significantly increased with increasing BMI.
In the multivariate model, conditions that were independently associated with an increased likelihood of death due to 2009 H1N1 infection were BMI >40 (OR, 2.8; 95% CI, 1.4-5.9), age >50 years (OR, 2.1; 95% CI, 1.2-3.7), and a category of miscellaneous immunosuppressive conditions that included congenital immunodeficiency, asplenia, and adrenal disorders and that excluded cancer, transplantation, receipt of immunosuppressive drugs, and human immunodeficiency virus infection (OR, 3.9; 95% CI, 1.6-9.5) ( Table 3) . Asthma was negatively associated with death (OR, 0.5; 95% CI, 0.3-0.9). After observing that 75% of the case patients who died and had a BMI >40 had a BMI >45, we re-analyzed the logistic regression model using an upper threshold of BMI >45, which yielded a higher risk estimate (OR, 4.2; 95% CI, 1.9-9.4) but similar estimates for age (OR, 2.1; 95% CI, 1.2-3.9), asthma, and miscellaneous immunosuppressive conditions (OR, 3.7; 95% CI, 1.5-9.1) ( Table 3) .
DISCUSSION
During the first 4 months of the pandemic, half of the California residents >20 years of age hospitalized with 2009 H1N1 infection were obese. The prevalence of BMI >30 in adults in this case series (51%) was 2.2 times and 1.5 times that estimated for all adults in California (23.2%) [17] and the United States (33%), respectively [18, 19] (Table 4 ). The prevalence of BMI >40 (19%) was at least 2.5 times higher than the estimated (44) 11 (26) 23 (38) .001
Age group, years .1
20-35
12 (52) 37 (34) 42 (33) 32 (30) 18 (29) 18 (43) 22 (36) 36-49 5 (22) 17 (15) 18 (14) 37 (34) 14 (22) prevalence in the United States (2.8% of US men and 6.9% of US women), and the prevalence of BMI >45 was at least 10-fold higher than national estimates (11.3% vs 1.1%) [19] . Obese persons were also more likely to die once hospitalized due to 2009 H1N1 infection. After adjusting for co-morbidities and other risk factors, extreme obesity (BMI >40) was independently significantly associated with death due to 2009 H1N1 infection. In addition, further sub-analysis demonstrated that case patients with BMI >45 had a 4.2-fold increased odds of dying, with a case-fatality proportion of 34%. A model using an upper threshold of BMI >50 showed similar odds of death as a model using an upper threshold of BMI >45 (data not shown).
Other investigators have described obese persons requiring hospitalization and critical care for 2009 H1N1 infection. Early in the pandemic, 9 of 10 severely ill adults requiring intensive care in Michigan had a BMI >30, and 7 had a BMI >40 [4] . A national study involving .200 hospitalized case patients found that 26 of 100 adults (26%) with BMI information had a BMI >40 [5] . For patients with 2009 H1N1 infection requiring intensive care, 35 (74%) of 47 in Utah [6] , 21 (36%) of 58 in Mexico [7] , 10 (31%) of 32 in Spain [8] , and 56 (33%) of 168 in Canada [9] had a BMI >30. In Mexico and Canada, mortality rates for obese case patients were similar to those for nonobese case patients [7, 9] . Once the pandemic had spread to the Southern Hemisphere, 26% of 601 critically ill patients in Australia and New Zealand [11] had a BMI .35, and 45% of 75 patients in Chile had a BMI >30 [12] . Diabetes and BMI >30 were the most frequently identified underlying conditions among case patients who died due to 2009 H1N1 infection who were .20 years of age worldwide [10] .
In the study most comparable to ours, obesity data from 594 case patients who were hospitalized with or died from 2009 H1N1 infection reported to the CDC were compared with estimates from the population-based 2003-2006 National Health and Nutrition Examination Survey (NHANES). In this study, obesity in case patients who died was defined by descriptions in medical records and death certificates; in patients without height information, the presence of obesity was estimated. The authors found that BMI >40 was associated with an increased risk of hospitalization for 2009 H1N1 infection with or without comorbidity (OR, 4.9 [95% CI, 2.4-9.9] and 4.7 [95% CI, 1.3-17.2], respectively). Both BMI >30 and BMI >40 were associated with increased risk of death in case patients without certain conditions associated by ACIP with severe influenza (OR, 3.1 [95% CI, 1.5-6.6] and 7.6 [95% CI, 2.1-27.9], respectively) [20] . The key findings from our study corroborate their findings and are strengthened by our study design and use of extensive data from a large cohort of hospitalized case patients, allowing additional comprehensive analysis. We were able to assess the role of chronic neurologic, hematologic, nondiabetes metabolic and immunosuppressive disorders identified as risk factors by h Includes Parkinson disease, dementia, status-post cerebrovascular accident, intraventircular hemmorhage, hydrocephalus status-post ventriculoperitoneal shunt, central nervous system malignancy, microcephaly, myasthenia gravis, chronic encephalopathy, muscular dystrophy, multiple sclerosis, para/quadriplegia, neurodegenerative disease not otherwise specified, and peripheral neuropathy.
i Includes status-post gastrostomy tube placement, gastritis, cholelithiasis, history of small bowel obstruction, short gut syndrome, pyloric stenosis, Hirschsprung disease, diverticulosis/diverticulitis, chronic hepatitis/ cirrhosis, biliary atresia, pancreatic insufficiency, gastroparesis, necroenterocolitis, ulcerative colitis, Chrohns disease, and chronic graft versus host disease.
j Includes Staphylococcus aureus of all susceptibility patterns (23 case patients), group A Streptococcus (9), Streptococcus pneumoniae (14), gram-negative rods (16) , and other bacteria (14) .
ACIP-information that is not available in the NHANES data. In addition, our ability to directly calculate BMI enabled us to analyze standard BMI categories and provides evidence that BMI >40 is an independent risk factor in hospitalized adults for death from 2009 H1N1 infection. The odds of death observed among our case patients increased at the more extreme end of the spectrum (eg, BMI >45); our data do not support the finding that, in the absence of other risk factors, moderately obese persons (eg, BMI 30-39) have an increased risk of dying once hospitalized. It is plausible that obesity might increase the risk of severe and fatal influenza. Excessive weight gain (>18 kg) may increase the risk of developing community-acquired pneumonia [21] . Obesity can impede pulmonary function. Obese patients allocate a disproportionately high percentage of total body oxygen consumption to respiratory work, resulting in reduced functional residual capacity and expiratory volume [22, 23] . A subsequent ventilation-perfusion abnormality may decrease ventilatory reserve and predispose the obese to respiratory failure after even mild pulmonary challenges [22, 23] . Obstructive sleep apnea is present in 40% of obese persons and is associated with systemic hypertension, pulmonary hypertension, and cor pulmonale [24] [25] [26] . Obese persons are at increased risk of developing pulmonary emboli and aspiration pneumonia [24] . Extremely obese persons may develop a sustained increase in arterial carbon dioxide tension due to chronic daytime hypoventilation [24] . Obese patients needing intensive care for acute lung injury have prolonged mechanical ventilation and hospital stay, compared with nonobese patients [27] [28] [29] [30] . In addition to its effects on pulmonary function, obesity is frequently but not always associated with diabetes, hypertension, hyperlipidemia, cardiovascular disease and higher overall mortality [23] . However, in our study, an increased odds of mortality from obesity among case patients with a BMI >40 persisted in multivariate analysis after adjustment for reported co-morbidities.
Neither obesity nor morbid obesity has previously been identified as increasing the risk of severe seasonal influenza in humans [14, [31] [32] [33] [34] [35] [36] [37] [38] . However, in limited studies, obese mice infected with seasonal influenza virus had a 6-fold higher fatality rate and diminished pulmonary expression of proinflammatory cytokines (interferon a and b, interleukin 6, and tumor necrosis factor a), compared with nonobese mice [39] ; obese mice also have significantly impaired influenza-specific memory T cell function in the lung [40] . An association between seasonal influenza and obesity may have been obscured by an underreporting of obesity or a focus on the co-morbidities associated with obesity (eg, asthma, diabetes, and cardiovascular disease) or on the disproportionate numbers of frail elderly individuals affected, who account for most deaths from seasonal influenza and who are often underweight [41, 42] .
Over three-quarters of obese adults in our series received antiviral medications. However, in roughly two-thirds of this population, treatment was initiated .48 h after onset of symptoms. Although obese and nonobese case patients did not differ in the median time from onset of symptoms to hospitalization, obese case patients were more likely to be treated later, compared with nonobese case patients ( Table 2 ). Patients at high risk for severe disease due to 2009 H1N1, including hospitalized patients, are recommended for treatment with a neuraminidase inhibitor as soon as possible [43] . Standard dosing of oseltamivir may be adequate for obese patients [44] , but confirmatory data are warranted on whether higher doses and longer duration of neuraminidase inhibitor therapy might improve outcomes in critically ill obese patients with seasonal or 2009 H1N1 infection.
Our data are subject to several limitations. Data were extracted from nonstandardized medical records. Case ascertainment was based on passive reporting by clinicians, and underreporting of influenza may have occurred because of poor recognition and the general nonspecificity of influenza-like illness symptoms. In addition, the limited availability of confirmatory laboratory testing may have contributed to under-detection of cases. Although potentially resulting in fewer reported cases, none of these limitations would have introduced selection bias. It is unclear whether co-morbidities were more likely to be undiagnosed in obese case patients in this series. Although smokers are more likely to develop pneumonia, data on history of tobacco use were not available. However, diagnoses of chronic pulmonary disease (eg, chronic obstructive pulmonary disease) or lung cancer may be an indicator of compromised pulmonary function attributable to smoking.
Other important considerations include the availability of height and weight data, which were preferentially available for fatal case patients, with 95% of fatal case patients having BMI data available, compared with 85% of non-fatal case patients. Furthermore, there were several significant differences in case patients with BMI data, compared with case patients without BMI data available, including race/ethnicity and presence of underlying cardiac disease. Of note, none of the factors associated with missing BMI data were associated with death in the multivariate analysis, and they were unlikely to bias key findings.
In summary, obesity, a common and increasing condition worldwide, was more prevalent among adults hospitalized with 2009 H1N1 infection than it was among the adult population for California and the United States. Although obese persons may have multiple co-morbidities that contribute to the risk of severe influenza, persons with class III or extreme obesity, particularly with a BMI >45, appear to be at higher risk for death due to 2009 H1N1 infection independent of other risk factors. Even if elevated BMI is only a reflection of undiagnosed co-morbidities or other underlying risk factors, measurement of BMI can still serve as convenient measure for identifying adults at high risk for severe disease. This would be analogous to recommendations for older age groups for seasonal influenza immunization, because their increased age is a reflection of a high prevalence of underlying medical conditions that predispose them to severe influenza. Similarly, BMI categories could be added to current high risk groups for prioritization of antiviral use and influenza vaccine immunization in times of supply shortages.
The World Health Organization recommended incorporation of 2009 H1N1 as a component in the 2010-2011 seasonal influenza vaccine with the expectation that the virus will continue to circulate in the near future and cause disease. When 2009 H1N1 is known to be circulating, clinicians should maintain a high level of suspicion in patients with known risk factors for influenza complications, as well as in obese adults presenting with influenza-like symptoms; these patients should be carefully monitored and managed with prompt and aggressive treatment with antiviral agents. More data, including data on the pathophysiology of influenza in the obese, are needed.
